The Pituitary World News Podcast

S8E2: Recorlev (Levoketoconazole)

February 18, 2022

In today's podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug RecorlevĀ® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing's Syndrome. While this podcast contains medical and technical terminology, we encourage patients to listen to it and discuss it with their physicians.

Podbean App

Play this podcast on Podbean App